Department of Neurosciences, Tor Vergata University of Rome and IRCCS Fondazione Santa Lucia, Rome, Italy.
Muscle Nerve. 2010 Sep;42(3):445-8. doi: 10.1002/mus.21718.
POEMS (polyneuropathy, organomegaly, endocrinopathy, M-band, and skin changes) syndrome is characterized by chronic progressive polyneuropathy and plasma-cell dyscrasia. A major diagnostic criterion of POEMS is elevation of circulating vascular endothelial growth factor (VEGF), which is believed to play a pathogenic role in this disease. We report a case of POEMS that presented as relapsing acute inflammatory demyelinating polyneuropathy, in which complete remission after intravenous immunoglobulin (IVIg) treatment was unexpectedly observed. At clinical nadir, the VEGF level was 30-fold higher, and the soluble form of VEGF receptor 2 (sVEGFR2), which acts as a decoy for VEGF, was 2.7-fold lower than normal. These changes combined might contribute to the pathogenesis of POEMS, inducing vascular permeability and tissue edema. At 9-month follow-up, during clinical remission, VEGF and sVEGFR2 were near normal values. sVEGFR2 reduction is a new finding in POEMS. IVIg treatment may benefit POEMS patients with acute neuropathy by downgrading VEGF release induced by inflammatory cytokines.
POEMS(多发性神经病、器官肿大、内分泌病、M 带和皮肤改变)综合征的特征为慢性进行性多发性神经病和浆细胞增生异常。POEMS 的主要诊断标准之一是循环血管内皮生长因子(VEGF)升高,据信其在该病中发挥致病作用。我们报告了一例 POEMS 病例,其表现为复发性急性炎症性脱髓鞘性多发性神经病,静脉注射免疫球蛋白(IVIg)治疗后意外观察到完全缓解。在临床最低值时,VEGF 水平升高 30 倍,而作为 VEGF 诱饵的可溶性 VEGF 受体 2(sVEGFR2)降低 2.7 倍,低于正常水平。这些变化可能共同导致 POEMS 的发病机制,诱导血管通透性和组织水肿。在 9 个月的随访中,处于临床缓解期时,VEGF 和 sVEGFR2接近正常水平。sVEGFR2 减少是 POEMS 的一个新发现。IVIg 治疗可能通过降低炎症细胞因子诱导的 VEGF 释放,有益于急性神经病的 POEMS 患者。